# Knott David M Jr: Form 13F holdings

An institutional investment manager in SYOSSET, NY. SEC CIK 1892770.

- Quarter ended: 2026-06-30
- Filed: 2026-08-12
- Reported value: $189.2m
- Positions: 84 (86 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1892770/000110465926094536/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Alphabet Inc-Cl C (GOOGL)](/companies/googl.md) | Common | $32.3m | 17.1% | 91,420 |  | Unchanged |
| [Apollo Global Management, Inc. (APO)](/companies/apo.md) | Common | $26.6m | 14.1% | 225,000 |  | Unchanged |
| [Syndax Pharmaceutical, Inc. (SNDX)](/companies/sndx.md) | Common | $9.6m | 5.1% | 437,245 |  | Added +15,245 |
| [Xeris Biopharma Holdings, Inc. (XERS)](/companies/xers.md) | Common | $8.4m | 4.4% | 1,060,000 |  | Unchanged |
| [Travere Therapeutics, Inc. (TVTX)](/companies/tvtx.md) | Common | $8.4m | 4.4% | 147,282 |  | Added +6,649 |
| [Protagonist Therapeutics, Inc (PTGX)](/companies/ptgx.md) | Common | $7.7m | 4.1% | 63,000 |  | Unchanged |
| [Bridgebio Pharma, Inc. (BBIO)](/companies/bbio.md) | Common | $6.9m | 3.7% | 92,850 |  | Added +2,850 |
| [Iovance Biotherapeutics, Inc. (IOVA)](/companies/iova.md) | Common | $6.7m | 3.5% | 1,600,000 |  | Unchanged |
| Alkermes PLC | Common | $6.4m | 3.4% | 121,759 |  | Added +1,759 |
| [JPMorgan Chase & Co. (JPM)](/companies/jpm.md) | Common | $5.9m | 3.1% | 18,098 |  | Reduced −1,379 |
| Janus Henderson AAA CLO ETF | Common | $4.7m | 2.5% | 93,528 |  | Unchanged |
| LPL Financial Holdings Inc. | Common | $4.6m | 2.5% | 16,500 |  | Unchanged |
| [Cogent Biosciences Inc. (COGT)](/companies/cogt.md) | Common | $4.3m | 2.3% | 111,081 |  | Added +7,081 |
| [TG Therapeutics, Inc. (TGTX)](/companies/tgtx.md) | Common | $3.7m | 1.9% | 66,839 |  | Reduced −23,162 |
| [Catalyst Pharmaceuticals, Inc. (CLST)](/companies/clst.md) | Common | $3.6m | 1.9% | 114,000 |  | New +114,000 |
| [Agios Pharmaceutical, Inc. (AGIO)](/companies/agio.md) | Common | $3.5m | 1.9% | 95,058 |  | Added +2,000 |
| [Viridian Therapeutics, Inc. (VRDN)](/companies/vrdn.md) | Common | $3.3m | 1.8% | 181,000 |  | Unchanged |
| [Relmada Therapeutics, Inc. (RLMD)](/companies/rlmd.md) | Common | $3.1m | 1.6% | 451,000 |  | Added +11,700 |
| [Arcus Biosciences, Inc. (RCUS)](/companies/rcus.md) | Common | $2.5m | 1.3% | 81,241 |  | Unchanged |
| Cybin Inc | Common | $2.4m | 1.3% | 370,000 |  | Added +20,000 |
| SPDR S&P Biotech ETF | Common | $2.4m | 1.3% | 15,000 |  | Unchanged |
| [Rezolute, Inc. (RZLT)](/companies/rzlt.md) | Common | $1.9m | 1.0% | 370,000 |  | Unchanged |
| [AllianceBernstein Holding L.P. (AB)](/companies/ab.md) | Common | $1.7m | 0.9% | 48,000 |  | Unchanged |
| [Madrigal Pharmaaceuticals, Inc. (MDGL)](/companies/mdgl.md) | Common | $1.6m | 0.9% | 3,000 |  | Added +1,000 |
| [AtriCure, Inc. (ATRC)](/companies/atrc.md) | Common | $1.4m | 0.8% | 51,400 |  | Unchanged |
| [DocGo, Inc. (DCGO)](/companies/dcgo.md) | Common | $1.4m | 0.7% | 2,670,850 |  | Unchanged |
| [Ardelyx, Inc. (ARDX)](/companies/ardx.md) | Common | $1.3m | 0.7% | 263,168 |  | Added +56,168 |
| [Ultragenyx Pharmaceutical Inc. (RARE)](/companies/rare.md) | Common | $1.3m | 0.7% | 38,069 |  | Added +5,000 |
| The Panagram BBB-B CLO ETF | Common | $1.3m | 0.7% | 47,807 |  | Unchanged |
| [Cullinan Therapeutics, Inc. (CGEM)](/companies/cgem.md) | Common | $1.3m | 0.7% | 69,182 |  | Added +44,982 |
| [Johnson & Johnson (JNJ)](/companies/jnj.md) | Common | $1.3m | 0.7% | 4,922 |  | Unchanged |
| [Vera Therapeutics, Inc. (VERA)](/companies/vera.md) | Common | $1.1m | 0.6% | 26,000 |  | Unchanged |
| [Orchestra Biomed Holdings, Inc. (OBIO)](/companies/obio.md) | Common | $1.1m | 0.6% | 253,651 |  | Unchanged |
| [Spruce Biosciences, Inc. (SPRB)](/companies/sprb.md) | Common | $1.1m | 0.6% | 20,000 |  | New +20,000 |
| Connect Biopharma Holdings Limited | Common | $1.1m | 0.6% | 444,862 |  | Added +57,027 |
| iShares Biotechnology ETF | Common | $1.0m | 0.6% | 5,500 |  | Unchanged |
| [Biogen Inc. (BIIB)](/companies/biib.md) | Common | $864.2k | 0.5% | 4,000 |  | Unchanged |
| [Pfizer Inc. (PFE)](/companies/pfe.md) | Common | $778.7k | 0.4% | 32,337 |  | Unchanged |
| [Apple Inc. (AAPL)](/companies/aapl.md) | Common | $721.7k | 0.4% | 2,494 |  | Unchanged |
| [Canadian Natural Resources Limited (CNQ)](/companies/cnq.md) | Common | $663.6k | 0.4% | 16,800 |  | Unchanged |
| [Pelthos Therapeutics, Inc. (PTHS)](/companies/pths.md) | Common | $623.8k | 0.3% | 22,073 |  | Added +1,000 |
| [International Business Machines (IBM)](/companies/ibm.md) | Common | $602.4k | 0.3% | 2,142 |  | Unchanged |
| [Microsoft Corporation (MSFT)](/companies/msft.md) | Common | $596.8k | 0.3% | 1,600 |  | Unchanged |
| [Verastem Inc. (VSTM)](/companies/vstm.md) | Common | $592.1k | 0.3% | 155,000 |  | Added +51,000 |
| [Kura Oncology, Inc. (KURA)](/companies/kura.md) | Common | $578.9k | 0.3% | 52,767 |  | Unchanged |
| [Solid Bioscience Inc. (SLDB)](/companies/sldb.md) | Common | $561.5k | 0.3% | 56,208 |  | Added +9,065 |
| DuPont de Nemours, Inc. | Common | $511.0k | 0.3% | 3,767 |  | New +3,767 |
| [Insmed Incorporated (INSM)](/companies/insm.md) | Common | $453.5k | 0.2% | 4,253 |  | New +4,253 |
| [LB Pharmaceuticals, Inc. (LBRX)](/companies/lbrx.md) | Common | $420.8k | 0.2% | 12,965 |  | New +12,965 |
| [CareDx, Inc. (CDNA)](/companies/cdna.md) | Common | $388.5k | 0.2% | 13,630 |  | New +13,630 |
| [Q32 Bio Inc (QTTB)](/companies/qttb.md) | Common | $387.4k | 0.2% | 30,412 |  | New +30,412 |
| [Enliven Therapeutics, Inc. (ELVN)](/companies/elvn.md) | Common | $313.8k | 0.2% | 6,183 |  | New +6,183 |
| [Ryman Hospitality Properties, Inc. (RHP)](/companies/rhp.md) | Common | $308.5k | 0.2% | 2,400 |  | Unchanged |
| [Broadcom, Inc. (AVGO)](/companies/avgo.md) | Common | $268.2k | 0.1% | 710 |  | Unchanged |
| [Kimberly-Clark Corporation (KMB)](/companies/kmb.md) | Common | $263.4k | 0.1% | 2,400 |  | Unchanged |
| [Nvidia Corp (NVDA)](/companies/nvda.md) | Common | $256.1k | 0.1% | 1,280 |  | Unchanged |
| [Boston Scientific Corporation (BSX)](/companies/bsx.md) | Common | $256.1k | 0.1% | 6,000 |  | New +6,000 |
| Wave Life Science Ltd. | Common | $232.4k | 0.1% | 40,000 |  | Unchanged |
| [Rain Enhancement Technologies Holdco Inc (RAIN)](/companies/rain.md) | Common | $210.5k | 0.1% | 101,686 |  | Unchanged |
| [Mondelez International, Inc. (MDLZ)](/companies/mdlz.md) | Common | $173.5k | <0.1% | 3,000 |  | Unchanged |
| [Quanta Services, Inc. (PWR)](/companies/pwr.md) | Common | $126.7k | <0.1% | 176 |  | Unchanged |
| [Bristol-Myers Squibb Company (BMY)](/companies/bmy.md) | Common | $115.2k | <0.1% | 2,000 |  | Reduced −11,622 |
| [Eastern Bankshares Inc (EBC)](/companies/ebc.md) | Common | $111.2k | <0.1% | 5,000 |  | Unchanged |
| [Alphabet Inc CL A (GOOGL)](/companies/googl.md) | Common | $107.2k | <0.1% | 300 |  | Unchanged |
| [Legacy Housing Corporation (LEGH)](/companies/legh.md) | Common | $105.1k | <0.1% | 4,000 |  | Unchanged |
| [Corteva, Inc. (CTVA)](/companies/ctva.md) | Common | $102.1k | <0.1% | 1,206 |  | Unchanged |
| iShares Russell Mid-Cap Growth | Common | $101.8k | <0.1% | 695 |  | Unchanged |
| [United Rental, Inc. (URI)](/companies/uri.md) | Common | $88.4k | <0.1% | 78 |  | Unchanged |
| [Invivyd, Inc. (IVVD)](/companies/ivvd.md) | Common | $87.2k | <0.1% | 100,000 |  | Unchanged |
| [Amazon.com Inc. (AMZN)](/companies/amzn.md) | Common | $71.5k | <0.1% | 300 |  | Unchanged |
| [Danaher Corporation (DHR)](/companies/dhr.md) | Common | $34.3k | <0.1% | 180 |  | Unchanged |
| [Dow Inc. (DOW)](/companies/dow.md) | Common | $33.0k | <0.1% | 1,206 |  | Unchanged |
| [FS KKR Capital Corp. (FSK)](/companies/fsk.md) | Common | $30.2k | <0.1% | 2,875 |  | New +2,875 |
| International Game Technology PLC | Common | $26.8k | <0.1% | 2,500 |  | Unchanged |
| [Blackstone Group LP (BX)](/companies/bx.md) | Common | $24.7k | <0.1% | 210 |  | Unchanged |
| [United Healthcare Corp. (UNH)](/companies/unh.md) | Common | $23.7k | <0.1% | 57 |  | Unchanged |
| [Occidental Petroleum Corporation (OXY)](/companies/oxy.md) | Common | $22.8k | <0.1% | 469 |  | Reduced −194 |
| [Thermo Fisher Scientific, Inc. (TMO)](/companies/tmo.md) | Common | $22.6k | <0.1% | 45 |  | Unchanged |
| [Salesforce, Inc. (CRM)](/companies/crm.md) | Common | $12.1k | <0.1% | 77 |  | Unchanged |
| [Starwood Property Trust, Inc. (STWD)](/companies/stwd.md) | Common | $6.6k | <0.1% | 400 |  | Unchanged |
| [Kyndryl Holdings Inc. (KD)](/companies/kd.md) | Common | $4.8k | <0.1% | 428 |  | Unchanged |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4.3k | <0.1% | 194 |  | New +194 |
| [GE HealthCare Technologies Inc (GEHC)](/companies/gehc.md) | Common | $3.2k | <0.1% | 50 |  | Unchanged |
| [Wabtec Corporation (WAB)](/companies/wab.md) | Common | $1.6k | <0.1% | 6 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ADMA Biologics, Inc. (ADMA)](/companies/adma.md) | Common | $0 | 0.0% | 0 |  | Sold out −60,200 |
| Arcellx Inc | Common | $0 | 0.0% | 0 |  | Sold out −19,433 |
| Biohaven Pharmaceutical Holding Co. Ltd | Common | $0 | 0.0% | 0 |  | Sold out −60,720 |
| Catalyst Pharmaceuticals, Inc. | Common | $0 | 0.0% | 0 |  | Sold out −120,000 |
| Centessa Pharmaceuticals PLC | Common | $0 | 0.0% | 0 |  | Sold out −39,000 |
| [Cytokinetics, Incorporated (CYTK)](/companies/cytk.md) | Common | $0 | 0.0% | 0 |  | Sold out −23,644 |
| DuPont de Nemours, Inc. | Common | $0 | 0.0% | 0 |  | Sold out −3,767 |
| [Evolus, Inc. (EOLS)](/companies/eols.md) | Common | $0 | 0.0% | 0 |  | Sold out −99,338 |
| FS KKR Capital Corp. | Common | $0 | 0.0% | 0 |  | Sold out −2,875 |
| [Jasper Therapeutics, Inc. (JSPR)](/companies/jspr.md) | Common | $0 | 0.0% | 0 |  | Sold out −160,789 |
| [LENZ Therapeutics, Inc. (LENZ)](/companies/lenz.md) | Common | $0 | 0.0% | 0 |  | Sold out −33,732 |
| [Mereo BioPharm Group PLC (MREO)](/companies/mreo.md) | Common | $0 | 0.0% | 0 |  | Sold out −300,337 |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-094536. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.